Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion

Brain Research

Volumn 1038, Issue 2, 2005, Pages 163-170

  Xu, Zao C ^a   Ling, Guangyi ^a   Sahr, Robert N ^b   Neal Beliveau, Bethany S ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

6 OHDA; Asymmetry; Autoradiography; Dopamine receptor; Lateralization; Striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; OXIDOPAMINE; SPIPERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; CORPUS STRIATUM; INTERMETHOD COMPARISON; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RECEPTOR BINDING; STATISTICAL SIGNIFICANCE; SUBSTANTIA NIGRA; UPREGULATION;

EID: 14744303440     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.01.033     Document Type: Article

References (46)

1. R.L. Albin, A.B. Young, and J.B. Penney The functional anatomy of basal ganglia disorders Trends Neurosci. 12 1989 366 375
2. J.A. Angulo, H. Coirini, M. Ledoux, and M. Schumacher Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat Brain Res. Mol. Brain Res. 11 1991 161 166
3. M.A. Ariano Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway Brain Res. 443 1988 204 214
4. H.S. Bracha, D.J. Seitz, J. Otemaa, and S.D. Glick Rotational movement (circling) in normal humans: sex difference and relationship to hand, foot and eye preference Brain Res. 411 1987 231 235
5. M. Buonamici, C. Caccia, M. Carpentieri, L. Pegrassi, A.C. Rossi, and G. Di Chiara D-1 receptor supersensitivity in the rat striatum after unilateral 6-hydroxydopamine lesions Eur. J. Pharmacol. 126 1986 347 348
6. P. Calabresi, M. De Murtas, N.B. Mercuri, and G. Bernardi Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission Ann. Neurol. 31 1992 366 673
7. P. Calabresi, N.B. Mercuri, and G. Bernardi Chemical modulation of synaptic transmission in the striatum Prog. Brain Res. 99 1993 299 308
8. D. Centonze, P. Gubellini, B. Picconi, P. Calabresi, P. Giacomini, and G. Bernardi Unilateral dopamine denervation blocks corticostriatal LTP J. Neurophysiol. 82 1999 3575 3579
9. C. Cepeda, N.A. Buchwald, and M.S. Levine Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated Proc. Natl. Acad. Sci. U. S. A. 90 1993 9576 9580
10. D.W. Choi, and S.M. Rothman The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death Annu. Rev. Neurosci. 13 1990 171 182
11. J.A. Clemens, and L.A. Phebus Dopamine depletion protects striatal neurons from ischemia-induced cell death Life Sci. 42 1988 707 713
12. H. Coirini, M. Schumacher, J.A. Angulo, and B.S. McEwen Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment Eur. J. Pharmacol. 186 1990 369 371
13. I. Creese, D.R. Burt, and S.H. Snyder Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity Science 197 1977 596 598
14. K.L. Drew, R.A. Lyon, M. Titeler, and S.D. Glick Asymmetry in D-2 binding in female rat striata Brain Res. 363 1986 192 195
15. C.R. Gerfen, T.M. Engber, L.C. Mahan, Z. Susel, T.N. Chase, F.J. Monsma Jr., and D.R. Sibley D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons Science 250 1990 1429 1432
16. S.D. Glick, B. Zimmerberg, and T.P. Jerussi Adaptive significance of laterality in the rodent Ann. N. Y. Acad. Sci. 299 1977 180 185
17. S.D. Glick, P.A. Hinds, and R.M. Shapiro Cocaine-induced rotation: sex-dependent differences between left- and right-sided rats Science 221 1983 775 777
18. M.Y. Globus, M.D. Ginsberg, W.D. Dietrich, R. Busto, and P. Scheinberg Substantia nigra lesion protects against ischemic damage in the striatum Neurosci. Lett. 80 1987 251 256
19. M.Y. Globus, M.D. Ginsberg, S.I. Harik, R. Busto, and W.D. Dietrich Role of dopamine in ischemic striatal injury: metabolic evidence Neurology 37 1987 1712 1719
20. W.C. Graham, A.R. Crossman, and G.N. Woodruff Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity: I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat Brain Res. 514 1990 93 102
21. B. Guerin, C. Silice, P. Mouchet, C. Feuerstein, and P. Demenge Changes of the striatal 3H-spiperone binding 3-6 weeks after nigrostriatal denervation and after two years Life Sci. 37 1985 953 961
22. E.D. Hall, P.K. Andrus, J.A. Oostveen, J.S. Althaus, and P.F. VonVoigtlander Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons Brain Res. 742 1996 80 88
23. F. Hefti, E. Melamed, and R.J. Wurtman Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization Brain Res. 195 1980 123 137
24. K.S. Hsu, C.C. Huang, C.H. Yang, and P.W. Gean Presynaptic D2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum Brain Res. 690 1995 264 268
25. X.T. Hu, S.R. Wachtel, M.P. Galloway, and F.J. White Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation J. Neurosci. 10 1990 2318 2329
26. J.N. Joyce Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine: II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment Exp. Neurol. 113 1991 277 290
27. D.S. Kim, M.S. Szczypka, and R.D. Palmiter Dopamine-deficient mice are hypersensitive to dopamine receptor agonists J. Neurosci. 20 2000 4405 4413
28. M.S. Levine, K.L. Altemus, C. Cepeda, H.C. Cromwell, C. Crawford, M.A. Ariano, J. Drago, D.R. Sibley, and H. Westphal Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice J. Neurosci. 16 1996 5870 5882
29. M.S. Levine, Z. Li, C. Cepeda, H.C. Cromwell, and K.L. Altemus Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices Synapse 24 1996 65 78
30. J.F. Marshall, R. Navarrete, and J.N. Joyce Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis Brain Res. 493 1989 247 257
31. R. Miller, and R.J. Beninger On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animals with unilateral depletion of striatal dopamine Prog. Neurobiol. 36 1991 229 256
32. B.S. Neal, and J.N. Joyce Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors Synapse 11 1992 35 46
33. K.A. Neve, C.A. Altar, C.A. Wong, and J.F. Marshall Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury Brain Res. 302 1984 9 18
34. S.M. Nicola, J. Surmeier, and R.C. Malenka Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens Annu. Rev. Neurosci. 23 2000 185 215
35. M.J. O'Neill, C.A. Hicks, M.A. Ward, G.P. Cardwell, J.M. Reymann, H. Allain, and D. Bentue-Ferrer Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia Eur. J. Pharmacol. 352 1998 37 46
36. Z.P. Pang, G.Y. Ling, M. Gajendiran, and Z.C. Xu Asymmetrical changes of excitatory synaptic transmission in dopamine-denervated striatum after transient forebrain ischemia Neuroscience 114 2002 317 326
37. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates Second ed. 1986 Academic Press San Diego
38. M.L. Porceddu, O. Giorgi, G. De Montis, S. Mele, L. Cocco, E. Ongini, and G. Biggio 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors Life Sci. 41 1987 697 706
39. W.A. Pulsinelli, J.B. Brierley, and F. Plum Temporal profile of neuronal damage in a model of transient forebrain ischemia Ann. Neurol. 11 1982 491 498
40. Z.H. Qin, J.F. Chen, and B. Weiss Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors J. Neurochem. 62 1994 411 420
41. Y. Ren, X. Li, and Z.C. Xu Asymmetrical protection of neostriatal neurons against transient forebrain ischemia by unilateral dopamine depletion Exp. Neurol. 146 1997 250 257
42. S.M. Rothman, and J.W. Olney Glutamate and the pathophysiology of hypoxic-ischemic brain damage Ann. Neurol. 19 1986 105 111
43. L.H. Schneider, R.B. Murphy, and E.E. Coons Lateralization of striatal dopamine (D2) receptors in normal rats Neurosci. Lett. 33 1982 281 284
44. U. Ungerstedt 6-Hydroxy-dopamine induced degeneration of central monoamine neurons Eur. J. Pharmacol. 5 1968 107 110
45. Z.C. Xu, W. Chwang, X. Li, X. Chen, and P. He Gender difference in dopamine concentration and postischemic neuronal damage in neostriatum after unilateral dopamine depletion Exp. Neurol. 158 1999 182 191
46. B. Zimmerberg, S.D. Glick, and T.P. Jerussi Neurochemical correlate of a spatial preference in rats Science 185 1974 623 625